Rishi Garg, MD
Sports Medicine · Arcadia, CANPI 1164642583
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (32.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Arthrex accounts for 82.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $2,823 and has fallen 89.0% since, to $309 in 2025.
Across 52 payments — averaging $138.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$6K
- Smith+Nephew$547
- Goode Surgical Inc$249
- Saxum Surgical, Inc.$128
- Zimmer Biomet$65
- Team_makena_llc$61
- plus $204 from 7 others
What the payments were for
- Consulting fees$2,27532%
- Speaking & faculty fees$2,00028%
- Travel & lodging$5728%
- Food & beverage$2,33933%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 34 | $5,932 |
| Smith+Nephew | 5 | $547 |
| Goode Surgical Inc | 1 | $249 |
| Saxum Surgical, Inc. | 2 | $128 |
| Zimmer Biomet | 2 | $65 |
| Team_makena_llc | 1 | $61 |
| Lifenet Health | 1 | $52 |
| Globus Medical | 1 | $50 |
| Innovation Technologies Inc | 1 | $28 |
| Medline Industries LP | 1 | $23 |
| Catalyst Orthoscience | 1 | $20 |
| Trevena, Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,186 in reported general payments places this provider in the 65th percentile of 662 sports medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 185 | $1,988 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 52 | $507 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 16 | $168 |
| Methylprednisolone | 18 | $102 |
| Meloxicam | 66 | $87 |
| Tramadol Hcl | 24 | $61 |
| Ibuprofen | 12 | $48 |
| Zolpidem Tartrate | 12 | $47 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Arcadia
- Neal ElattracheLos Angeles$51M
- Nathaniel CohenLos Gatos$6.4M
- Thomas KnappSanta Monica$2.5M
- Michael FreehillStanford$1.6M
- Allan MishraMenlo Park$1.5M
- Heinz Hoeneckela Jolla$1.4M
- Seth ShermanStanford$1.1M
- Stephan YacoubianBurbank$1M
- Stephen Snydervan Nuys$922K
- Deryk JonesSan Carlos$915K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.